spot_img
HomeEthereumLatest news on Cell and gene therapy CRO market Research Report by...

Latest news on Cell and gene therapy CRO market Research Report by 2035

Roots Analysis has done a detailed study on “Cell and Gene Therapy CROs Market, 2022-2035”, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.

Key Market Insights

  • More than 105 CROs claim to provide a wide range of preclinical and clinical services for the development of advanced therapy medicinal products.
  • The current market landscape features the presence of established and emerging players, majority of the service providers offer research and analytical services for both cell and gene therapies at different scales of operation.
  • Around 1,330 cell and gene therapy focused clinical trials have been registered across the globe; most of the trials are focused on evaluating therapy candidates for the treatment of various oncological indications
  • In pursuit of a competitive edge and to eventually establish themselves as one-stop shops, stakeholders have actively entered into mutually beneficial partnerships
  • We expect industry stakeholders to continue to forge strategic alliances with niche / specialized players engaged in this domain to further augment their respective product offerings
  • Our proprietary analysis highlights several potential acquisition partners for cell and gene therapy service providers across different geographies
  • Our proprietary total cost of ownership model provides an informed estimate of direct and indirect expenses for setting up a contract research facility in different regions, over a span of 20 years
  • The market is expected to grow at a CAGR of over 21% in the coming decade; the opportunity is likely to be well distributed across areas of expertise, therapeutic areas, scales of operation and key geographical regions

Table of Contents


1.                     PREFACE

1.1.                  Scope of the Report

1.2.                  Market Segmentation

1.3.                  Research Methodology

1.4.                  Key Questions Answered

1.5.                  Chapter Outlines

2.                     EXECUTIVE SUMMARY

2.1.                  Chapter Overview

3.                     INTRODUCTION

3.1.                  Chapter Overview

3.2.                  Overview of Contract Research Organizations (CROs)

3.3.                  Type of Services Offered by CROs

3.4.                  Classification of CROs

3.5.                  Role of CROs in Development of Advanced Therapy Medicinal Products (ATMPs)

3.6.                  Advantages of Outsourcing Operations to CROs

3.7.                  Risks Associated with Outsourcing to CROs

3.8.                  Future Perspectives

4.                     GUIDE TO OUTSOURCING

4.1.                  Chapter Overview

4.2.                  Outsourcing Cell and Gene Therapy Research 

4.3.                  Guiding Models of Outsourcing

4.4.                  Selecting an Appropriate Outsourcing Model

4.5.                  Selecting a CRO Partner

4.6.                  Role of CROs in Drug Development

4.7.                  Concluding Remarks

5.                     MARKET LANDSCAPE

5.1.                  Chapter Overview

5.2.                  Cell and Gene Therapy CROs: Overall Market Landscape

6.                     COMPANY PROFILES

6.1.                  Chapter Overview

6.2.                  Players based in North America

6.2.1.               Altasciences

6.2.1.1.             Company Overview

6.2.1.2.            Service Portfolio

6.2.1.3.            Recent Developments and Future Outlook

6.2.2.               Allucent (Formerly Known as CATO SMS)

6.2.3.               Charles River Laboratories

6.2.4.               Creative Biolabs

6.2.5.               IQVIA

6.2.6.               Medpace

6.2.7.               PPD

6.2.8.               Precision for Medicine

6.2.9.               QPS

6.3.                  Players based in Europe

6.3.2.               Evotec

6.3.3.               ICON

6.3.4.               Syneos Health

6.4.                  Players based in Asia-Pacific

6.4.1.               CMIC Group

6.4.2.               Labcorp

7.                     COMPETITIVE BENCHMARKING

7.1.                  Chapter Overview

7.2.                  Assumptions and Key Methodology

7.3.                  Competitive Benchmarking by Region

7.4.                  Concluding Remarks

8.                     PARTNERSHIPS AND COLLABORATIONS

8.1.                  Chapter Overview

8.2.                  Partnership Models

8.3.                  Cell and Gene Therapy CROs: Partnerships and Collaborations

9.                    MERGERS AND ACQUISITIONS

9.1.                 Chapter Overview

9.2.                 Merger and Acquisition Models

9.3.                 Cell and Gene Therapy CROs: Mergers and Acquisitions

10.                   KEY ACQUISITION TARGETS

10.1.                Chapter Overview

10.2.                Scoring Criteria and Key Assumptions

10.3.                Scope and Methodology

10.4.                Potential Strategic Acquisition Targets Amongst Small Players

10.5.                Potential Strategic Acquisition Targets Amongst Mid-sized Players

11.                   LIKELY PARTNER ANALYSIS FOR CELL THERAPY CROs

11.1.                Chapter Overview

11.2.                Scoring Criteria and Key Assumptions

11.3.                Scope and Methodology

11.4.                Key Potential Strategic Partners for Cell Therapy CROs

12.                   LIKELY PARTNER ANALYSIS FOR GENE THERAPY CROs

12.1.                Chapter Overview

12.2.                Scoring Criteria and Key Assumptions

12.3.                Scope and Methodology

12.4.                Key Potential Strategic Partners for Gene Therapy CROs

13.                   CLINICAL TRIAL ANALYSIS

13.1.                Chapter Overview

13.2.                Scope and Methodology

13.3.                Cell Therapies: Analysis by Number of Clinical Trials

13.4.                Cell Therapies: Analysis by Enrolled Patient Population

13.5.                Gene Therapies: Analysis by Number of Clinical Trials

13.6.                Gene Therapies: Analysis by Enrolled Patient Population

                        14.                   TOTAL COST OF OWNERSHIP FOR CELL AND GENE THERAPY CONTRACT             RESEARCH ORGANIZATIONS

14.1                 Chapter Overview

14.2.                Key Parameters

14.3.                Assumptions and Methodology

14.4                 Sample dataset for the estimation of total cost of ownership

15.                   MARKET FORECAST AND OPPORTUNITY ANALYSIS

15.1.                Chapter Overview

15.2.                Key Assumptions and Methodology

15.3.                Global Cell and Gene Therapy CROs Market, 2022-2035

16.                   SWOT ANALYSIS

16.1.                Chapter Overview

16.2.                Strengths

16.3.                Weaknesses

16.4.                Opportunities

16.5.                Threats

16.6.                Comparison of SWOT Factors

17.                   CONCLUSION

17.1.                Chapter Overview

18.                   INTERVIEW AND SURVEY TRANSCRIPTS

18.1.                Chapter Overview

18.2.                CATO SMS

18.3.                Changhai Hospital, Second Military Medical University

18.4.                University of Colorado

16.                   APPENDIX 1: TABULATED DATA

17.                   APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

To view more details on this report, click on the link:

https://www.rootsanalysis.com/reports/view_document/cell-and-gene-therapy-cros-market/230.html

Learn from experts:  do you know about these emerging industry trends?

Key Trends in Non-Viral Transfection Market

Deep Learning-based Interoperability: Advanced Neural Networks Mimicking the Human Brain

Learn from our recently published whitepaper: –

Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Learn more about Roots Analysis consulting services: 

Roots Analysis Consulting – the preferred research partner for global firms

Contact:

Ben Johnson

+1 (415) 800 3415

Ben.johnson@rootsanalysis.com

RELATED ARTICLES
- Advertisment -
Google search engine

Most Popular

Recent Comments

spaceman slot

https://indianphotorestoration.com/

https://thepamperedpoochmobilegrooming.com/

https://sbcoolsculpting.com/

slot bet 100

spaceman slot

https://www.ismerelyshop.com/

https://www.survivalswimkids.com/